Umbilical cord blood cell therapy in an animal model of Alzheimer's disease

March 26, 2008

A novel strategy based on targeted immune suppression using human umbilical cord blood cells may improve the pathology and cognitive decline associated with Alzheimer’s disease, based on the results of a study in a mouse model of this currently untreatable neurodegenerative condition, as described in a groundbreaking report in Stem Cells and Development.

Following a series of low-dose infusions of human umbilical cord blood cells into mice with Alzheimer’s-like disease, the amount of amyloid-ß and ß-amyloid plaques—hallmarks of Alzheimer’s pathology in the brain—was markedly reduced. Amyloid-ß induces an inflammatory response in the brain associated with the interaction of CD40 and CD40L, two pro-inflammatory molecules.

Human umbilical cord blood cell therapy was associated with suppression of CD40-CD40L activity, suggesting that this therapeutic approach modulates the activity of the immune system, offering the potential to target the pathogenic inflammatory response that may contribute to a variety of degenerative conditions, including Alzheimer’s disease.

Jun Tan, PhD, MD, and colleagues from USF (Tampa), Yale University (New Haven, CT), Cedars-Sinai Medical Center (Los Angeles, CA), Saneron CCEL Therapeutics (Tampa, FL), and Saitama Medical School (Japan), concluded that human umbilical cord blood cell-induced disruption of the CD40-CD40L interaction may alleviate the key pathologic changes in the brain associated with Alzheimer’s disease in a report entitled, “Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice.”

“Previously, challenging observations have reported phenomena suggesting the non-hematologic therapeutic potential of blood stem cells. What is novel about this paper is its application to Alzheimer’s disease, and a significant advance in characterizing the ameliorative mechanism of action” says Graham C. Parker, PhD, Editor-in-Chief of Stem Cells and Development, and a research professor in The Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine, Children's Hospital of Michigan.

Source: Mary Ann Liebert, Inc./Genetic Engineering News

Explore further: Air pollution may shorten telomeres in newborns

Related Stories

Air pollution may shorten telomeres in newborns

January 24, 2018
A study conducted before and after the 2004 closure of a coal-burning power plant in Tongliang, China, found children born before the closure had shorter telomeres than those conceived and born after the plant stopped polluting ...

Stem cell-rich cord blood donations could increase by 'nudging' parents, study suggests

January 11, 2018
It contains potentially lifesaving stem cells that can treat a host of blood-based cancers and other diseases. Yet the blood found in newborns' umbilical cords is almost always discarded as medical waste, rather than banked ...

A repurposed drug could open door to more stem cell transplants

December 20, 2017
A medication used to treat joint and skin conditions might also help people whose only hope of surviving cancer is receiving stem cells from a donor, according to research by a University of British Columbia scientist.

Umbilical cord blood improves motor skills in some children with cerebral palsy

October 30, 2017
An infusion of cells from a child's own umbilical cord blood appears to improve brain connectivity and motor function in children with spastic cerebral palsy, according to a randomized clinical trial published this week by ...

Doctors urged to discuss cord blood donations early in pregnancy

October 30, 2017
(HealthDay)—A leading group of U.S. pediatricians is encouraging parents to donate to public cord blood banks after the birth of their children.

Cord blood improves motor function with cerebral palsy

November 29, 2017
(HealthDay)—Infusion of autologous umbilical cord blood improves whole brain connectivity and motor function in young children with cerebral palsy (CP), according to a study published online Oct. 28 in Stem Cells Translational ...

Recommended for you

The first step in generating an artificial adrenal gland

January 30, 2018
In a new study, published in Cell Reports, researchers from Queen Mary University of London used cells derived from urine to take the first step in generating an artificial adrenal gland, which could help develop future treatments ...

Study proves 'muscle memory' exists at a DNA level

January 30, 2018
A study led by researchers at Keele University has shown for the first time that human muscles possess a 'memory' of earlier growth—at the DNA level.

Researchers cure lung fibrosis in mice with a gene therapy that lengthens telomeres

January 30, 2018
Idiopathic pulmonary fibrosis is a potentially lethal disease associated with the presence of critically short telomeres, currently lacking effective treatment. The Telomere and Telomerase Group at the Spanish National Cancer ...

Oestrogen causes neuroblastoma cells to mature into neurons

January 29, 2018
The female sex hormone oestrogen can perform an important role in neuroblastoma, a form of cancer mainly affecting young children. In laboratory experiments, researchers at Karolinska Institutet in Sweden demonstrate that ...

Researchers overcome obstacle for future stem cell therapies

January 25, 2018
Researchers have discovered a new technique that overcomes one of the major challenges of stem cell therapy.

Developing a roadside test for marijuana intoxication isn't as easy as it sounds

January 25, 2018
As the movement to legalize marijuana in the United States gains momentum, researchers worry about keeping the public safe, particularly on the roads. Recent studies in which marijuana users took controlled doses of cannabis ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.